| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | Canada | 3 | |
| #4 | Australia | 2 | |
| #5 | China | 2 | |
| #6 | Hong Kong | 2 | |
| #7 | African Regional Industrial Property Organization | 1 | |
| #8 | Brazil | 1 | |
| #9 | Germany | 1 | |
| #10 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Computer technology |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Medical preparations | |
| #5 | Bioinformatics | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wagner Ralf | 19 |
| #2 | Graf Marcus | 7 |
| #3 | Graf Markus | 7 |
| #4 | Bieler Kurt | 7 |
| #5 | Deml Ludwig | 6 |
| #6 | Osterrieder Nikolaus | 5 |
| #7 | Beer Martin | 5 |
| #8 | Trapp Sascha | 5 |
| #9 | Raab David | 4 |
| #10 | Notka Frank | 4 |
| Publication | Filing date | Title |
|---|---|---|
| DE10260805A1 | Method and device for optimizing a nucleotide sequence for expression of a protein | |
| EP1394258A1 | Non-human herpesviruses as vectors | |
| AP200202508A0 | The genome of the HIV-1 inter-subtype (C/B') and use thereof. | |
| EP1156112A1 | Synthetic gagpol genes and their uses | |
| EP0449116A1 | DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof |